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Prophylactic management of sudden cardiac death
has been a challenge in the clinical practice. In the
US, a large number of clinical randomized trials
evaluating the eﬃcacy of implantable cardioverter
deﬁbrillators (ICDs) regarding the mortality partic-
ularly that associated with arrhythmic events, have
been completed and have demonstrated that ICDs
have a great potential to improve the prognosis of
high risk patients with SCD,1,2) and are superior to
antiarrhythmic drug therapy. At the same time, the
indications (of the ACC/AHA/NASPE guidelines3))
and national coverage (on the statement of CMS4)) of
ICDs for primary prevention have become extended
by sequentially adding the inclusion criteria from
those randomized trials. As a result, the total number
of ICD implants is estimated to increase to more than
150,000/year, in 2005. On the contrary, we do not
have any reliable evidence in Japan with regard to
the role of ICDs in either secondary or primary
prevention of SCD. Accordingly, the medical care in
this area (prophylaxis of SCD) is remarkably
delayed, as compared to that in western countries.
The number of ICD implants clearly reﬂects this
delay, i.e., approximately only 2,600 ICD implanta-
tions are expected in Japan this year. However, at the
present time, it is recommended that we avoid an
easy application of the US criteria to our clinical
practice because of several reasons; of which, the
most important issue is that inter-racial diﬀerences
are presumed to be present in terms of the distribu-
tion of structural heart disease, content of the
medical care and even the incidence of SCD.
Watanabe et al.5) demonstrated in their article
published in the current issue of the Journal of
Arrhythmia that the incidence of out-of-hospital
cardiac arrests (OHCA) was 62.3/100,000/year. In
approximately a half of those (47%), the OHCA was
due to a cardiac etiology. Moreover, the incidence of
a bystander witnessed ventricular ﬁbrillation (VF)
was 2.5/100.000/year. These results are almost
consistent with a previous study6) from Osaka city,
which similarly made a population-based evaluation
using the Utstein style analysis. According to those
reports, the total incidence of SCDs is anticipated to
be roughly 30,000–35,000/year, suggesting the
incidence of SCDs/population is about one third
that of the US.
Another signiﬁcant observation from this study
was that not only age and gender, but also the
collapse to the ECG time was associated with the
appearance of VF. Since the appearance of VF and
bystander CPR were related signiﬁcantly to a better
prognosis for the patients, this data may provide
important information for constructing future strat-
egies for emergency medicine.
It is also an interesting ﬁnding that younger
patients are more likely to have VF episodes during
the nighttime than are older patients. Although the
authors do not have any direct evidence except for
the fact that a few patients actually had later
disorders, it seems reasonable to speculate that an
acute coronary syndrome or Brugada syndrome were
two possible causes for the nighttime SCD in the
younger population. An age-related diﬀerence in the
circadian variation of SCD has been previously
shown in Europe7) in which the younger population
had a biphasic distribution with peaks in the morning
and afternoon, whereas the older population demon-
strated a monophasic distribution with a peak only in
the morning that may have reﬂected an age-related
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variability in the etiology. It is conceivable that there
might be inter-racial diﬀerences in the circadian
variation, and thus also in the distribution of the
etiology of SCD in the younger population. However
further studies with a large population are needed to
draw this conclusion.
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